摘要
目的观察生长抑素与生长激素临床序贯应用治疗肠外瘘的疗效.方法比较1993年1月～1998年12月和1999年1月～2003年12月前后两个阶段时间分别采用生长抑素和序贯应用生长抑素、生长激素的临床治疗效果,并对其结果进行分析.结果临床序贯应用生长抑素、生长激素治疗肠外瘘可明显提高自愈率(93.8%vs 61.1%,P＜0.05),明显缩短住院时间(22.8±11.5d vs 31.7±14.2d;P＜0.05),两者间差异均有显著性意义.结论临床序贯应用生长抑素、生长激素治疗肠外瘘,可促进肠外瘘的愈合、缩短住院时间,提高自愈率.
Objective: To observe the clinic effect of the application of somatostatin and growth hormone. Methods: Retrospectively analysing the therapeutic results of somatostatin in the first phase of Jan. 1993~Dec. 1993 and the application of somatostatin and growth hormone in the second phase of Jan. 1999~Dec. 2003. Results: The spontaneous cure rate was significantly higher in patients treated with combined rhGH and somatostatin than in those treated only with somatostatin (93.8% vs 61.1%, P <0.05). The hospitalized days were significantly shorten (22.8±11.5d vs 31.7±14.2d; P <0.05). Conclusion: The clinical application of rhGH and somatostin is an effective therapeutic method for the treatment of enteric fistula. It may promote the spontaneous cure of enteric fistula and shorten the hospitalized days.
出处
《中国现代医学杂志》
CAS
CSCD
2004年第15期106-108,共3页
China Journal of Modern Medicine
关键词
肠瘘
生长抑素
生长激素
intestinal fistula
somatostatin
somatotropin
